Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Telomir Pharmaceuticals, Inc. Common Stock | StockGist | StockGist

Companies
TELO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings TELOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Telomir Pharmaceuticals, Inc. Common Stock

Filed Feb 12, 2026

Accepted Feb 11, 2026, 7:00 PM ET

CIK 0001971532

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Telomir Pharmaceuticals, Inc.

Person Type

IN

CUSIP: 87975F104

Amendment History

2 filings

SCHEDULE 13G
Original
Sep 18, 20250001104659-25-091366
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Feb 12, 20260001104659-26-014568

Recent Filings

Telomir Pharmaceuticals, Inc. Common Stock2 days ago

Telomir Pharmaceuticals, Inc. Common Stock2 days ago

Telomir Pharmaceuticals, Inc. Common Stock1 months ago

Telomir Pharmaceuticals, Inc. Common Stock1 months ago

Telomir Pharmaceuticals, Inc. Common Stock2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice